SCHEMBL16502

SCHEMBL16502

C=CC(=O)C=C(c1ccccc1)c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.56
NFE2L2 Q16236 1/20 0.43
ALDH1A1 P00352 3/20 0.42
CES1 P23141 3/20 0.42
CES2 O00748 2/20 0.42
TSHR P16473 2/20 0.42
DAO P14920 1/20 0.42
NAPRT Q6XQN6 1/20 0.42
CA12 O43570 2/20 0.42
CA1 P00915 2/20 0.42
CA2 P00918 2/20 0.42
CA9 Q16790 2/20 0.42
TDP1 Q9NUW8 4/20 0.41
MAPK1 P28482 2/20 0.41
TGM2 P21980 1/20 0.41
L3MBTL1 Q9Y468 3/20 0.39
MAPT P10636 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
CYP2C19 P33261 2/20 0.39
MEN1 O00255 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28065922 0.86 CES1 (0.50) AKT1NFE2L2ALDH1A1CES1CES2
SCHEMBL6154724 0.79 AKT1 (0.52) AKT1NFE2L2ALDH1A1CES1CES2
SCHEMBL669455 0.79 CA12 (0.50) AKT1ALDH1A1CA12CA1CA2
SCHEMBL63954 0.77 CES1 (0.50) AKT1NFE2L2ALDH1A1CES1CES2
SCHEMBL776748 0.76 AKT1 (0.48) AKT1NFE2L2ALDH1A1CES1CES2
SCHEMBL1320542 0.75 MEN1 (0.49) ALDH1A1CES1CES2CA1CA2
SCHEMBL3661967 0.75 KDM4E (0.48) ALDH1A1TSHRNAPRTCA12CA1
SCHEMBL1490953 0.75 GSK3B (0.49) ALDH1A1CA12CA1CA2CA9
SCHEMBL16061419 0.75 ALDH5A1 (0.50) AKT1ALDH1A1CES2CA12CA1
SCHEMBL7786865 0.75 CA1 (0.50) ALDH1A1TSHRCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4076456-A1 SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOF Université de Strasbourg (FR) 2022-10-26 EP disclosed
WO-2021123174-A1 SIGMA-1 RECEPTOR LIGANDS AND THERAPEUTIC USES THEREOF UNIVERSITE DE STRASBOURG (FR) 2021-06-24 WO disclosed
CN-110183320-A A kind of polyenoid diketone anti-tumor compounds 四川大学 2019-08-30 CN disclosed
EP-3356343-A1 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS Syngenta Participations AG (CH) 2018-08-08 EP disclosed
EP-3160948-A1 BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS Astrazeneca AB (SE) 2017-05-03 EP disclosed
EP-3104701-A1 FACTOR XIA INHIBITORS Merck Sharp & Dohme Corp. (US) 2016-12-21 EP disclosed
WO-2016001631-A1 BENZOXAZINONE AMIDES AS MINERALOCORTICOID RECEPTOR MODULATORS ASTRAZENECA AB (SE) 2016-01-07 WO disclosed
WO-2015123090-A1 FACTOR XIA INHIBITORS MERCK SHARP & DOHME CORP. (US) 2015-08-20 WO disclosed
WO-2014035872-A1 TRICYCLIC ALKYNES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN AMGEN INC. (US) 2014-03-06 WO disclosed
WO-2013173382-A1 BENZOTHIOPHENE SULFONAMIDES AND OTHER COMPOUNDS THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN AMGEN INC. (US) 2013-11-21 WO disclosed
WO-2010005384-A1 KETONE PYRIDINE ANALOGUES AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISORDERS ASTRAZENECA AB (SE) 2010-01-14 WO disclosed
WO-2010005385-A1 2-AMINO-6-ALKYL SUBSTITUTED PYRIDINE DERIVATIVES USEFUL AS P2Y12 INHIBITORS 308 ASTRAZENECA AB (SE) 2010-01-14 WO disclosed
WO-2009011627-A1 PYRIDINE COMPOUNDS AND THEIR USE AS P2Y12 ANTAGONISTS ASTRAZENECA AB (SE) 2009-01-22 WO disclosed
WO-2009007300-A2 SUBSTITUTED AMINO-QUINAZOLINONES, MEDICAMENTS COMPRISING SAID COMPOUND, THEIR USE AND THEIR METHOD OF MANUFACTURE BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-01-15 WO disclosed
WO-2008085119-A1 NEW PYRIDINE ANALOGUES VIII 518 ASTRAZENECA AB (SE) 2008-07-17 WO disclosed
WO-2007090627-A1 METHODS BASED ON UV RADIATION-INDUCED CHANGES IN A CRYSTAL OF A COMPOUND AND DEVICE FOR DETERMINING A THREE-DIMENSIONAL STRUCTURE OF SUCH COMPOUND EMBL (DE) 2007-08-16 WO disclosed
EP-1558621-A2 METHOD FOR THE PRODUCTION OF COMPOUNDS CONTAINING PALLADIUM (0) Umicore AG & Co. KG (DE) 2005-08-03 EP disclosed
WO-2004039819-A2 METHOD FOR THE PRODUCTION OF COMPOUNDS CONTAINING PALLADIUM (0) UMICORE AG & CO. KG (DE) 2004-05-13 WO disclosed
EP-1159362-A1 SUBSTANCE FOR BONDING, COATING AND SEALING, CONSISTING OF CYANOACRYLATES AND ALDEHYDE OR KETONE CONDENSATION PRODUCTS Henkel Kommanditgesellschaft auf Aktien (DE) 2001-12-05 EP disclosed
WO-2000032709-A1 SUBSTANCE FOR BONDING, COATING AND SEALING, CONSISTING OF CYANOACRYLATES AND ALDEHYDE OR KETONE CONDENSATION PRODUCTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 2000-06-08 WO disclosed